Biocom is hosting the Campbell Alliance to present the updated findings to its Dealmakers’ Intentions Survey, the only forward-looking measure of deal-making activity in the pharmaceutical and biotech industries. While there are many quality sources of information that look historically at past deal trends, this survey offers a prospective view of the partnering and licensing landscape for the year ahead. Registration at the door and networking begins at 7 a.m., or register online here.